Ernexa Therapeutics Inc. ($ERNA)
Filing Information
| Accession Number | 0001104659-26-016680 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
8,000,000
Total Value
$2,000,000.00
P&L
-44.8% ($896,400.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Feb 10, 2026 | Purchase | 4,000,000 | $0.50 | $2,000,000.00 | 6,779,440 | Direct | โ | View Details | |
10% Owner | Warrants to Purchase Common Stock | Derivative | Feb 10, 2026 | Purchase | 4,000,000 | โ | โ | 4,000,000 | Direct | โ | View Details |